SRPL Board Approves ₹100 Crore Fundraising, Appoints Directors, Schedules AGM
Shree Ram Proteins Limited (SRPL) approved its Q3 FY2026 results and plans to raise ₹100 crore. The company will appoint four new directors and scheduled its 15th, 16th AGMs and an EGM for March 5, 2026. A portion of funds will be used for acquiring Sova Agrotech. However, auditors flagged material uncertainty about the company's going concern status due to defaults.
The company's ability to continue as a going concern is in doubt, as stated by the auditor. This, coupled with a ₹100 crore fundraising plan and acquisition, indicates potentially high stakes and significant financial implications for the company and its stakeholders.
While the company is undertaking positive corporate actions like fundraising and board appointments, the auditor's report highlights significant going concern issues and defaults, casting a strong negative shadow on the overall outlook.
Shree Ram Proteins Limited (SRPL) announced the outcome of its Board Meeting held on February 5, 2026. The Board approved the standalone un-audited financial results for the quarter ended December 31, 2025.
Key decisions included the appointment of internal auditors for FY 2023-24 and 2024-25, and the appointment of a cost auditor for FY 2025-26 and 2026-27. The company also approved the appointment of a Company Secretary in Practice as Secretarial Auditor for five years, subject to member approval.
Furthermore, the Board approved the appointment of four new directors: Ms. Naaz Jaiswal, Mr. Jayvir Vajubhai Kuvadiya, Mr. Akash Sureshbhai Gajera, and Mr. Yogeshbhai Chandubhai Dhanani, all subject to member approval in the upcoming General Meeting. The Board also approved a proposal to increase the authorized share capital and alter the Memorandum of Association, contingent on member approval.
A significant approval was the proposal to raise funds aggregating up to ₹100 crore through the issuance of equity shares and/or other eligible securities. A portion of these funds, up to ₹30 crore, is earmarked for the acquisition of a controlling stake in Sova Agrotech Private Limited, which involves settling an One Time Settlement (OTS) payment and acquiring land, plant, and machinery for ₹24.75 crore.
The Board also approved the sale of a piece of land located in Rajkot, subject to member approval. The company has scheduled its 15th Annual General Meeting (AGM) for March 5, 2026, at 11:00 a.m., its 16th AGM for March 5, 2026, at 1:30 p.m., and an Extra Ordinary General Meeting (EGM) for March 5, 2026, at 3:30 p.m. The dispatch of the annual report and EGM notice is fixed for February 7, 2026. The closure of the share transfer book for these meetings is from February 27, 2026, to March 5, 2026. E-voting will be open from February 2, 2026, to March 4, 2026. The meeting commenced at 11:00 a.m. and concluded at 1:45 p.m.
However, the independent auditor's review report highlighted a material uncertainty regarding the company's ability to continue as a going concern due to defaults in loan repayments and statutory dues. The auditor noted inadequate disclosures and a lack of a proper going concern assessment by management. The company has accepted a one-time settlement (OTS) with Union Bank of India but has failed to meet subsequent installment deadlines, with a new OTS accepted on January 24, 2025.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.